Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities:
Net income	$ 305,928	$ 203,158
Adjustments to reconcile net income to net cash used in operating activities:
Adoption of revenue recognition standard	0	48,709
Investment income	(94,985)	(91,486)
Depreciation and amortization	13,130	12,953
Equity-based compensation	36,977	29,867
Net realized and unrealized (gain) loss from consolidated funds’ investments	(53,559)	48,188
Amortization (accretion) of original issue and market discount of consolidated funds’ investments, net	(4,298)	(2,020)
Income distributions from corporate investments in funds and companies	102,763	126,810
Other non-cash items	2,630	777
Cash flows due to changes in operating assets and liabilities:
Net cash used in operating activities	(986,061)	(28,901)
Cash flows from investing activities:
Purchases of U.S. Treasury and other securities	(538,095)	(338,039)
Proceeds from maturities and sales of U.S. Treasury and other securities	696,991	242,074
Corporate investments in funds and companies	(98,707)	(145,041)
Distributions and proceeds from corporate investments in funds and companies	150,782	216,456
Purchases of fixed assets	(4,304)	(1,441)
Net cash provided by (used in) investing activities	206,667	(25,991)
Cash flows from financing activities:
Net proceeds from issuance of preferred units	0	173,669
Net cash provided by (used in) financing activities	1,132,782	(45,058)
Effect of exchange rate changes on cash	(760)	(1,045)
Net increase (decrease) in cash and cash-equivalents	352,628	(100,995)
Deconsolidation of funds	(81,855)	(12,315)
Cash and cash-equivalents, beginning balance	831,727	959,465
Cash and cash-equivalents, ending balance	1,102,500	846,155
Total cash and cash-equivalents	831,727	959,465
Consolidated Funds
Cash flows due to changes in operating assets and liabilities:
Increase (decrease) in accounts payable, accrued expenses and other liabilities	13,668	5,191
(Increase) decrease in dividends and interest receivable	(2,343)	528
(Increase) decrease in due from brokers	11,476	(2,745)
(Increase) decrease in receivables for securities sold	3,246	20,183
Increase in other assets	(1,804)	(151)
Increase (decrease) in payables for securities purchased	45,700	(20,588)
Purchases of securities	(2,796,529)	(2,474,617)
Proceeds from maturities and sales of securities	1,270,813	2,101,594
Cash flows from financing activities:
Distributions to non-controlling interests	(96,987)	(197,806)
Payment of debt issuance costs	(1,910)	(1,771)
Contributions from non-controlling interests	141,057	107,177
Proceeds from debt obligations issued by CLOs	1,867,459	633,055
Repayment on debt obligations issued by CLOs	(500,761)	(456,963)
Borrowings on credit facilities	416,838	0
Repayments on credit facilities	(372,000)	0
Cash and cash-equivalents, ending balance	403,071	286,730
Total cash and cash-equivalents	403,071	286,730
Oaktree Capital Group Excluding Consolidated Funds
Cash flows due to changes in operating assets and liabilities:
Increase in other assets	(1,413)	(1,129)
Decrease in net due from affiliates	309,389	74,328
Decrease in accrued compensation expense	(157,426)	(103,355)
Increase (decrease) in accounts payable, accrued expenses and other liabilities	10,576	(5,096)
Cash flows from financing activities:
Net proceeds from issuance of Class A units	0	219,750
Purchase of OCGH units	0	(219,525)
Repurchase and cancellation of units	(9,952)	(10,833)
Distributions to Class A unitholders	(130,325)	(121,757)
Distributions to preferred unitholders	(13,658)	0
Distributions to OCGH unitholders	(164,624)	(165,264)
Distributions to non-controlling interests	(2,355)	(2,555)
Payment of debt issuance costs	0	(2,235)
Cash and cash-equivalents, ending balance	699,429	559,425
Total cash and cash-equivalents	$ 699,429	$ 559,425